Page 132 - PCC10
P. 132
Materials and methods
21 men
Stem cell therapy
Prostatectomy
<6‐18 013 6
Endpoint: Safety
Exclusion:
1) Responders to erectile aids 2) Lack of sexual interest
3) Lack of subcutaneus fat
4) Recurrence of Pr C
IFD‐Grand Solutions 2017‐Sheikh/CVR
Adverse events
Evaluation of erectile function
08‐06‐2018 27
Legislation...
National Ethics Committee
Danish Data Protection Agency
Authorizations in relation to ATMP classification: European Clinical Trials Database (EudraCT) Danish Health and Medicinal Authority
Authorization of tissue establishment – CBP/OUH
Monitoring GCP unit/OUH
ClinicalTrials.gov
IFD‐Grand Solutions 2017‐Sheikh/CVR
37054 2008‐58‐0035
EudraCT 2013‐004220‐11
29035
Protocol 2013‐Afd.L NCT02240823
Page 126 of 135
132
